1. Home
  2. CPIX vs SLGL Comparison

CPIX vs SLGL Comparison

Compare CPIX & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

HOLD

Current Price

$4.12

Market Cap

34.1M

Sector

Health Care

ML Signal

HOLD

Logo Sol-Gel Technologies Ltd.

SLGL

Sol-Gel Technologies Ltd.

N/A

Current Price

$41.85

Market Cap

117.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CPIX
SLGL
Founded
1999
1997
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.1M
117.8M
IPO Year
2009
2018

Fundamental Metrics

Financial Performance
Metric
CPIX
SLGL
Price
$4.12
$41.85
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$50.00
AVG Volume (30 Days)
224.3K
16.0K
Earning Date
11-04-2025
11-20-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$41,278,349.00
$18,970,000.00
Revenue This Year
N/A
$121.82
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.21
62.04
52 Week Low
$1.85
$4.02
52 Week High
$7.25
$52.26

Technical Indicators

Market Signals
Indicator
CPIX
SLGL
Relative Strength Index (RSI) 73.82 53.60
Support Level $3.93 $38.91
Resistance Level $4.59 $43.12
Average True Range (ATR) 0.42 3.32
MACD 0.16 -0.09
Stochastic Oscillator 80.28 51.15

Price Performance

Historical Comparison
CPIX
SLGL

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

Share on Social Networks: